Hogan Lovells advises on the US$105 million Sudeep Pharma IPO
Dubai, 28 November 2025 – Hogan Lovells acted as US counsel to the book running lead managers on the US$105 million initial public offering of Sudeep Pharma Limited, a company engaged in the manufacturing of excipients and specialty ingredients for pharma, food and nutrition industries globally.
The Hogan Lovells Capital Markets team was led by Biswajit Chatterjee, Head of the India Practice and Dubai Office Managing Partner, with support from counsel Varun Jetly and senior associate Suchisubhra Sarkar.
The IPO was managed by ICICI Securities Limited and IIFL Capital Services Limited. The shares were listed on BSE and NSE on 28 November 2025.
About Hogan Lovells India practice
Hogan Lovells has built a market-leading India practice, drawing on the team’s extensive experience, deep local relationships and in-depth market knowledge. Our dedicated team, spanning our global network, supports Indian and foreign clients in exploring investment opportunities, raising capital, international trade, restructuring business, developing and financing infrastructure projects, investigations and compliance, and resolving disputes in and outside of India. As trusted legal advisors, we are recognized for an innovative approach to thought leadership, delivering timely and comprehensive insights on legal developments that shape our clients’ strategies and long-term business goals.
